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Measurement of reaction kinetics of
[177Lu]Lu-DOTA-TATE using a microﬂuidic system†
Z. Liu,a K. S. Schaap,a L. Ballemans,a R. de Zanger,b E. de Blois,b M. Rohdea and
E. Oehlke *a
Microﬂuidic synthesis techniques can oﬀer improvement over batch syntheses which are currently used
for radiopharmaceutical production. These improvements are, for example, better mixing of reactants,
more eﬃcient energy transfer, less radiolysis, faster reaction optimization, and overall improved reaction
control. However, scale-up challenges hinder the routine clinical use, so the main advantage is currently
the ability to optimize reactions rapidly and with low reactant consumption. Translating those results to
clinical systems could be done based on calculations, if kinetic constants and diﬀusion coeﬃcients were
known. This study describes a microﬂuidic system with which it was possible to determine the kinetic
association rate constants for the formation of [177Lu]Lu-DOTA-TATE under conditions currently used
for clinical production. The kinetic rate constants showed a temperature dependence that followed
the Arrhenius equation, allowing the determination of Arrhenius parameters for a Lu-DOTA conjugate
(A = 1.24 ± 0.05 × 1019 M−1 s−1, EA = 109.5 ± 0.1 × 10
3 J mol−1) for the ﬁrst time. The required reaction
time for the formation of [177Lu]Lu-DOTA-TATE (99% yield) at 80 °C was 44 s in a microﬂuidic channel
(100 μm). Simulations done with COMSOL Multiphysics® indicated that processing clinical amounts
(3 mL reaction solution) in less than 12 min is possible in a micro- or milli-ﬂuidic system, if the diameter of
the reaction channel is increased to over 500 μm. These results show that a continuous, microﬂuidic
system can become a viable alternative to the conventional, batch-wise radiolabelling technique.
Introduction
Recent years have seen increasing interest in the application of
microfluidics for the synthesis of radiopharmaceuticals. This
development started in the early 2000s with 18F or 11C contain-
ing compounds,1 but studies published in the last few years
also showed the advantage of microfluidics over conventional
methods for metal containing radiopharmaceuticals.2–7 The
reason for the success of microfluidics is that downsizing reac-
tion vessels to the micro-scale allows for better mixing of reac-
tants, more eﬃcient energy transfer, less radiolysis, faster reac-
tion optimization, and overall improved reaction control.1–8
However, limited throughput of microfluidic devices and the
diﬃcult interface between batch and continuous-flow pro-
cesses used for diﬀerent radiopharmaceutical preparation
steps still hinder the routine clinical use.9 Up to now, the clear
advantage of microfluidic systems lies in the possibility of
rapid reaction optimization with very low precursor consump-
tion as shown by Mate et al.3
The remaining challenge of translating those optimization
results to conventional (clinical) reaction vessels, but also to
various microfluidic reactor designs without adding extensive
additional experiments, could be addressed by determining
kinetic constants and diﬀusion coeﬃcients of the studied
systems and calculating expected reaction times for the clinical
applied reaction vessels. Additionally, the determined con-
stants could be used to optimize the design of reaction vessels
using computational fluid dynamics, as Haroun et al. showed
recently for the microfluidic synthesis of [11C]raclopride.10
Both diﬀusion coeﬃcients and kinetic constants can be
obtained with microfluidic systems. So called T-sensors or
H-cells have been successfully applied to determine diﬀusion
coeﬃcients of small molecules and proteins.11–13 And
Konermann et al. showed in the late 1990s that continuous-
flow methods under laminar flow conditions (as are used in
microfluidics) allow not only easy and eﬃcient determination
of chemical reaction kinetics but avoid the considerable
sample consumption typical for conventional continuous-flow
kinetic experiments.14–17 The most common application of
these systems can be found in time-resolved mass spectro-
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metry, an analytical method used for the study of chemical
kinetics or biological dynamics.18,19 A typical laminar
flow setup for continuous-flow experiments consists of two
capillaries through which the reactants are pumped to a
T-mixer, which is again connected to the capillary in which
the reaction takes place. The reaction process is measured
with various analytical methods (e.g. MS,18,19 IR,20 NMR21) at
diﬀerent lengths of the reaction capillary, equaling diﬀerent
time-points of the reaction.
In this paper, we present such a microfluidic setup for the
determination of kinetic association rate constants of radio-
pharmaceuticals. Considerations regarding the ability of our
setup to determine these constants can be found in the ESI.†
The reaction yields are determined by an ultra-high perform-
ance liquid chromatography (UHPLC) system, which is not
connected to the microfluidic system, a fact that currently
limits the studied reactions to those which do not occur
at room temperature. To show the working principle of
our method, we investigated the kinetic properties of the
reaction of [177Lu]LuCl3 with 1,4,7,10-tetraazacyclododecane-
N,N′,N′′,N′′′-tetraaceticacid[DOTA]0-Tyr3-octreotide (DOTA-TATE)
under conditions applied for the clinical preparation of
[177Lu]Lu-DOTA-TATE,22–24 and used the obtained results
for scale-up considerations. Although the formation of
[177Lu]Lu-DOTA-TATE has been studied extensively before,22,25
to the best of our knowledge no kinetic rate constants are known.
Materials and methods
Chemicals and reagents
For the (radio)synthesis of [177Lu]Lu-DOTA-TATE, [DOTA0,Tyr3]
octreotate kits prepared at Erasmus MC (Rotterdam,
The Netherlands) were used, which contained 0.303 mM
[DOTA0,Tyr3]octreotate, 0.64 M sodium ascorbate and 0.16 M
gentisic acid in 0.05 M HCl. The kits were stored at −20 °C
until use. The exact concentration of [DOTA0,Tyr3]octreotate
was determined by titration as described by Breeman et al.26
In short: based on an assumed concentration of DOTA-TATE, a
calibration curve containing ≥4 ratios of metal ions versus
DOTA-TATE in duplicate was prepared. Samples were analysed
by UHPLC with a base-to-base separation of DOTA-TATE
versus Lu-DOTA-TATE. At increasing amounts of Lu versus
DOTA-TATE in the titration, the peak corresponding with
DOTA-TATE decreased and the peak corresponding with
Lu-DOTA-TATE increased.
177LuCl3 (16 GBq g
−1) was produced in the Hoger Onderwijs
Reactor (HOR, Delft, The Netherlands). After irradiation, it was
dissolved in 0.05 M HCl to a final Lu concentration of appr.
0.13 mM or 0.26 mM. For non-radioactive experiments, LuCl3
solutions of the same concentrations were prepared by diluting
a 1 g L−1 Lu standard for ICP (Merck KGaA, Darmstadt,
Germany) with 0.05 M HCl. All Lu solutions were analysed by
Inductively Coupled Plasma – Optical Emission Spectrometry
(ICP-OES, Optima 4300DV, PerkinElmer USA) to determine the
exact concentrations. The scale-up radiolabelling tests were
done by spiking a non-radioactive LuCl3 solution with
177LuCl3
(0.1 MBq μL−1) obtained from IDB Holland.
All chemicals applied in this study were of the highest
grade, especially regarding metal purity, and were purchased
at Sigma-Aldrich or Alfa Aesar if not diﬀerently indicated.
Water was supplied from Milli-Q systems or Sigma-Aldrich.
Microfluidic set-up for kinetic experiments
The microfluidic set-up (Fig. 1) consisted of two 1 mL syringes
(Inkjet-F, BD) that were filled with the reactant solutions and
connected with capillary tubing (PEEK, 100 μm inner diameter
(ID), 20 cm length) to a static mixing tee (IDEX, M-540).
The static mixing tee contains a frit that enforces mixing of
reactants. A third capillary with varying inner diameter
(50–500 μm) and length (96–116 cm) was connected to the
mixing tee. Part of this third capillary was heated (60–90 °C)
and used as reaction channel. The distance between the
mixing tee and the heated part of the capillary was 20 cm
unless otherwise specified. The reaction capillary was heated
by winding it around a self-manufactured aluminium heating
block (see Fig. 1). The temperature of the heating block
was checked using a precision thermometer (Greisinger GTH
175/PT, ±1 °C).
The two syringes were controlled with syringe pumps
(1000 Aladdin single syringe pump) using flowrates between
1 and 160 μL min−1. The dispensing accuracy of the pumps
has been specified by the supplier as ±1%, which was verified
by weighing the amount of water pushed through the whole
setup at diﬀerent flowrates over time periods of 20 to 60 min.
Labelling procedures
All experiments were repeated at least 3 times. Before taking
the samples, the microfluidic setup was flushed with the reac-
tant solutions at the studied flowrates for at least twice the
dead volume of the system. Samples of 15 μL (unless otherwise
indicated) were taken at the end of the reaction capillary for
analysis. All experiments besides the standard synthesis were
done with non-radioactive LuCl3.
Standard synthesis of [177Lu]Lu-DOTA-TATE. The following
labelling conditions, which are based on the conditions
currently used for the clinical labelling at Erasmus MC,22–24 were
used as standard. The DOTA-TATE kit solution (0.303 ± 0.003 mM)
and the [177Lu]LuCl3 solution (0.260 ± 0.003 mM, 0.1 MBq μL−1)
Fig. 1 Microﬂuidic setup. The left picture shows capillary tubing,
mixing tee and the aluminium heating block. The right picture displays
the whole setup. During operation the heating block was isolated from
above with a Styropor® plate.
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were pushed separately through two inlets into the reac-
tion capillary (total flowrate 15–120 μL). The flowrate ratio was
2 : 1 (DOTA-TATE : Lu), giving a molar ratio of 2.33 : 1. The reac-
tion capillary was heated to 80.1 ± 0.2 °C, and the pH of the reac-
tion solution was 4.0–4.5. To be able to analyse the samples
accurately with the radio-detector, samples of 40 μL were taken.
Degradation experiments. To investigate the degradation of
the DOTA-TATE kits during storage at room temperature, three
1 mL syringes were filled with kit solution. The closed syringes
were stored in a fumehood (appr. 20 °C) for 1–3 days. After this
time, the DOTA-TATE kits were applied for labelling following
the standard synthesis of Lu-DOTA-TATE.
Temperature experiments. The influence of temperature on
the reaction kinetics was measured at 5 diﬀerent temperatures
(59.5, 70.2, 75.1, 80.1, and 88.5 °C). All other conditions were
kept the same as described in the standard synthesis.
Influence of diameter. The investigation of reaction
capillaries with diﬀerent diameters (50, 100, 150, and 254 μm
ID) required diﬀerent flowrates (3–240 μL min−1), and the
adjustment of the dead volume. Otherwise all reaction para-
meters were the same as in the standard synthesis.
Mixing of reactants. For this experiment, either a static
mixing tee or a normal tee (IDEX) were incorporated in the
microfluidic setup. The distance between the tee and the
heated part of the reaction capillary was reduced to 3.5 cm. All
other conditions followed the standard synthesis.
Analytical methods
The (radio)chemical yield of the labelling experiments was
checked by thin layer chromatography (TLC) or ultra-perform-
ance liquid chromatography (UHPLC).
For TLC, Whatman™, 3MM chromatography paper was
used with 50% acetonitrile in water as solvent.27 The labelled
compound had an Rf of 1, while the free radionuclide stayed at
the origin.
For UHPLC an UPLC® Acquity system (H-class, UPLC
column, Acquity UPLC HSS C18, 1.8 µm 2.1 × 50 mm column)
equipped with an autosampler manager module at 6 °C
and an Acquity PDA 2996 UV detector (Waters, Etten-Leur,
The Netherlands) and Empower 3 software (Waters, The
Netherlands) was used. A gradient of Methanol and 0.1%
TFA was set over 3 min with a flow of 0.5 mL min−1 (see
ESI†). Retention time of DOTA-TATE was ∼2.17 min, of
Lu-DOTA-TATE ∼2.28 min, and ∼0.34 min and ∼0.57 min for
free Lu. Radioactivity was monitored with an Osprey digital
multichannel analyser connected to a NaI detector, and dedi-
cated software (MetorX B.V, Goedereede, The Netherlands),
connected to the UHPLC system.
Data analysis
The kinetic data was fitted non-linearly using a second-order
kinetic model (neglecting the diﬀerent protonated species
of DOTA-TATE).28,29 The kinetic association rate constants (k)
obtained for diﬀerent temperatures were fitted non-linearly
using the Arrhenius equation.30 Details about the applied for-
mulas can be found in the ESI.†
Determination of diﬀusion coeﬃcients
The diﬀusion coeﬃcient of Lu3+ (D ¼ 2:14 109 m2 s1 at
20 °C) was calculated based on the Stokes–Einstein equation,31
while the one of [177Lu]Lu-DOTA-TATE was determined to be
1.9 ± 0.4 × 10−10 m2 s−1 at 20 ± 1 °C using a method described
by Miložič et al.11 (for details see ESI†). The diﬀusion co-
eﬃcient of DOTA-TATE was approximated to be the same as
the one for [177Lu]Lu-DOTA-TATE. All diﬀusion coeﬃcients
were adjusted to the required temperatures by using the
Stokes–Einstein equation.31
Computational modelling
Governing equations. The flow profile of the fluid in the
microfluidic set-up is governed by the continuity equation and
the Navier–Stokes equation for incompressible flow (constant
density):31
ð∇~vÞ ¼ 0 ð1Þ
ρ
@~v
@t
þ ρ~v∇~v ¼ ∇pþ μ∇2~v ð2Þ
where ~v is the velocity (m s−1), p is the pressure (Pa), ρ is the
density of the fluid (kg m−3) and μ is the dynamic viscosity of
the fluid (Pa s).
The convection–diﬀusion-reaction equation governs the
transport of chemical species:31
@ci
@t
þ~v∇ci ¼ Di∇2ci þ Ri ð3Þ
where Di is the diﬀusion coeﬃcient of the chemical species i
(m2 s−1), and ci denotes the concentration of the chemical
species i (mol m−3). Ri denotes the reaction rate of chemical
species i (mol m−3 s−1). This term represents the rate of for-
mation of the product and the rate of consumption of the
reactants.
Finally, the heat transfer process is governed by eqn (4):31
ρ
@cpT
@t
þ ρ~v∇ðcpTÞ ¼ λ∇2T þ q ð4Þ
where cp is the specific heat at constant pressure (J kg
−1 K−1),
λ is the thermal conductivity coeﬃcient (J m−1 s−1 K−1), and
q is the rate of heat production (J m−3 s−1).
Computational models. The system of diﬀerential equations
presented above has been solved numerically using the soft-
ware package COMSOL Multiphysics® and applying the Finite
Element Method (FEM).
Two 2-dimensional models were built to simulate the
microfluidic system with or without using a static mixing tee
in the experiment. For simulating the behaviour of a mixing
tee, the model assumed that the reactants are fully mixed at
the beginning of the reaction channel.
A T-shaped model simulated the behaviour of applying a
normal tee to combine the streams of reactants. The model
had two separate inlet streams where the lutetium solution
entered through the top inlet and DOTA-TATE was present in
the bottom inlet (Fig. 2). In this case, the reactants mix
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through diﬀusion as they progress along the reaction channel.
The steady state Navier–Stokes equation was solved to describe
the advection of the solution. The resolved velocity field was
then coupled to the convection term both in the mass trans-
port equation (eqn (3)) and in the heat transport equation
(eqn (4)). The boundary conditions and parameters used in
the models are listed in Tables 1 and 2.
Results and discussion
Kinetic properties of the formation of [177Lu]Lu-DOTA-TATE at
diﬀerent temperatures
The kinetics of the formation of [177Lu]Lu-DOTA-TATE were
determined using a microfluidic synthesis setup (total reaction
times of a few minutes) together with an UHPLC system
(analysis time of 3.5 min). This combination gave the
opportunity to scan several reaction parameters within one day
using non-radioactive LuCl3. To confirm the consistency
between non-radioactive and radioactive experiments, we did
experiments with lutetium solution that was spiked with
[177Lu]LuCl3 obtained from IDB Holland. The yield of the
radioactive experiment was measured both with the UV- (278 nm)
and the radio-detector (113 and 208 keV) of the UHPLC
system. Both measurements gave comparable results (see
Fig. 3), therefore all further experiments were done with non-
radioactive LuCl3 solution.
Fig. 4 shows the reaction yield of Lu-DOTA-TATE as a func-
tion of residence time for diﬀerent temperatures determined
in a capillary with 100 μm inner diameter. Due to optimal heat
and mass transfer in the microfluidic system much lower reac-
tion times (44 s at 80 °C for 99% yield) are needed than
those reported for conventional systems (8–15 min at pH 4
and 80 °C).25 The data shows also that the synthesis of
Lu-DOTA-TATE is highly temperature dependent, which has
been observed before for lanthanide DOTA-peptide conjugates,
but was never quantified.32 The most extensive reaction
Fig. 2 2-Dimensional model for the reaction capillary (100 μm ID, 1 m
length) connected to a normal tee. The legend depicts the velocity mag-
nitude (m s−1) of the ﬂuid. The average velocity of the Lu3+ solution at
inlet 1 is 0.08 m s−1, and the average velocity of DOTA-TATE solution at
inlet 2 is 0.16 m s−1.
Table 1 Boundary conditions for solving the system of diﬀerential
equations. ~n is the normal vector, U0 is the average velocity at the inlet,
p0 is the pressure at the outlet, c0,i denotes the concentration of the
chemical species i at the inlet, T0 is the initial temperature of the reac-
tion solution, and Tw is the desired reaction temperature at the heated
channel wall
Momentum Mass transfer Heat transfer
Wall ~v ¼ 0 ~n~Ni ¼ 0 T = Tw
Nˉi ¼ Di∇ci þ~νci
Inlet ~v ¼ U0~n ci = c0,i T = T0
Outlet p = p0 ~nðDi∇ciÞ ¼ 0 If~n~ν , 0
T = T0;
If~n~ν . 0
~n~j ¼ 0; ~j ¼ λΔT
Table 2 Physical parameters used for solving the system of diﬀerential
equations. For simpliﬁcation, as long as the temperature of the solution
is higher than 20 °C, the diﬀusion coeﬃcient is set as constant due to
the fact that the temperature of the solution could be heated up to the
desired temperature very quickly
Parameter Value
DLu3þ ðm2 s1Þ 2.41 × 10−9 (at 20 °C);
7.3 × 10−9 (above 20 °C)
DDOTA‐TATE; DLu‐DOTA‐TATEðm2 s1Þ 1.9 × 10−10 (at 20 °C);
6.5 × 10−10 (above 20 °C)
A (M−1 s−1) 1.24 × 1019
EA (J mol
−1) 109.5 × 103
cp (J kg
−1 K−1) 4.2 × 103
λ (J m−1 s−1 K−1) 0.6
ρ (kg m−3) 1000
μ (Pa s) 1.01 × 10−3
Fig. 3 Comparison of measured reaction yield of [177Lu]Lu-DOTA-TATE
for UV and radio-detection. The reaction was done in a 100 μm channel
at 80 °C.
Fig. 4 Dependence of formation of Lu-DOTA-TATE on temperature. All
reactions were done in a 100 μm channel. The data points for each
temperature were ﬁtted to an equation representing second order
kinetics.
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studies that are available for diﬀerent temperatures were done
recently for Sc-DOTA and Sc-DOTA-TATE complexes at four
diﬀerent temperatures (25, 40, 70, and 90 °C).33
The measured data was fitted for each temperature to a
second order rate equation. This neglects the fact that the for-
mation of metal-DOTA complexes is a process involving several
species (depending on the protonation status of the carboxylic
groups on the DOTA molecule) and also reversible inter-
mediate forms.29,34 However, the overall reaction has already
previously been considered a second order reaction.29 The
kinetic association rate constants that were obtained are given
in Table 3.
Fig. 5 shows the dependence of the kinetic association rate
constants on the temperature. The Arrhenius equation was
fitted to all data points (R2 = 0.991), which allowed the deter-
mination of the Arrhenius parameters for the studied reaction
under the applied conditions (A = 1.24 ± 0.05 × 1019 M−1 s−1,
EA = 109.5 ± 0.1 × 10
3 J mol−1, an Arrhenius plot (ln(k) vs. 1/T )
is shown in the ESI†). We were not able to find Arrhenius para-
meters for Lu-DOTA-TATE, Lu-DOTA or any similar lanthanide
complexes in literature. All accessible kinetic data has been
determined for temperatures around 25 °C.28,29,32,34
The obtained parameters were further used to estimate
kinetic association constants for other temperatures. Based on
these constants, the residence times needed to achieve 99%
radiochemical yield were calculated as a function of tempera-
ture for the conditions described in this paper (see Fig. 6). In a
reaction vessel that has optimal mass and heat transfer, reac-
tion times under one hour can be still achieved at 43 °C (t =
55 min). A slightly higher temperature, 52 °C, already allows
for a reaction time of under 20 min. The estimated kinetic rate
constant for 25 °C (0.813 M−1 s−1 = 4.88 × 10−2 mM−1 min−1)
is in the same order of magnitude as the one determined for
Lu-DOTA previously by electrophoresis (4.54 ± 0.24 × 10−2
mM−1 min−1 in 20 mM sodium acetate solution, pH 4.2)28 and
would lead to reaction times of 12 h in a reaction vessel with
optimal heat and mass transfer.
A point to consider when applying the here described
microfluidic method for the synthesis of [177Lu]Lu-DOTA-TATE
is the stability of clinical DOTA-TATE kits, which we used
in this study. Previous syntheses of [177Lu]Lu-DOTA-TATE at
Erasmus MC showed no detectable diﬀerences between newly
prepared and old, slightly yellow, DOTA-TATE kits, and there-
fore these older kits are often used for first research studies.
However, during our microfluidic experiments, we observed a
clear trend to slower kinetics, if kit solutions were not stored
at −20 °C in the dark, but had degraded over time (see Fig. 7).
Reasons for this degradation could be the instability of
ascorbate, which is added as radical scavenger and buﬀer to
the solution,35 and is known to degrade at high storage tem-
peratures, light, high pH values and in the presence of dis-
solved oxygen.36–38 Further investigation into the reasons for
this degradation was out of scope for this study, however, it is
an important point to mention, since this is the first time that
degradation of kit solution has been observed to aﬀect the
synthesis of [177Lu]Lu-DOTA-TATE.
Up-scaling to clinical relevant amounts
Applying a microfluidic system containing one reaction
capillary with 100 μm inner diameter for the clinical synthesis
of [177Lu]Lu-DOTA-TATE (currently 3 mL reaction solution at
Erasmus MC), is due to the low flowrates (≤15 μL min−1 for
Table 3 Kinetic association constants of Lu-DOTA-TATE for diﬀerent
temperatures
Temperature (°C) k (M−1 s−1) R2
88.5 ± 0.2 1868 ± 100 0.7861
80.1 ± 0.2 902 ± 16 0.9793
75.1 ± 0.2 396 ± 15 0.9553
70.2 ± 0.2 223 ± 10 0.9408
59.5 ± 0.2 60.4 ± 2.8 0.8327
Fig. 5 Dependence of kinetic association constants on temperature.
The data points were ﬁtted to the Arrhenius equation.
Fig. 6 Prediction of time needed to achieve 99% yield for
[177Lu]Lu-DOTA-TATE in a setup with optimal heat and mass transfer.
The graph was calculated using the Arrhenius parameters obtained in
this study.
Fig. 7 Dependence of Lu-DOTA-TATE formation on time of storage of
DOTA-TATE kit at room temperature. The reaction was done in a 100 μm
channel at 80 °C.
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complete conversion) certainly not feasible. However, there
exist two possibilities to increase the throughput of the micro-
fluidic system while keeping the residence time of the reaction
solution the same: (I) to apply parallel systems, and (II) to
increase the diameter of the reaction channel.9 While the
first option mainly poses the problem of designing such a
parallel system, increasing the diameter of the reaction
channel requires again considerations regarding optimal heat
transfer and diﬀusion limitations. Experimental results using
capillaries with diﬀerent inner diameters (up to 254 μm)
showed no diﬀerences in kinetics (Fig. 8).
To determine the influence of the capillary diameter on the
formation rate of [177Lu]Lu-DOTA-TATE for even higher dia-
meters, we modelled two system options: one where the reac-
tants were completely mixed at the beginning of the reaction
channel (for example by using a static mixing tee), and one
where the reactant solutions were added separately and mixing
occurred solely through diﬀusion (Fig. 9). The computational
results for the fully mixed model show that if complete mixing
is achieved at the beginning of the channel, only slightly
decreased yields are expected for [177Lu]Lu-DOTA-TATE when
increasing the channel diameter up to 1.5 mm (Fig. 9a). Fig. 9b
depicts the concentration profile of [177Lu]Lu-DOTA-TATE at
the end of the reaction channel. Most of the product is formed
at the walls, since the low velocities there (see Fig. 2) lead to a
longer residence time of the liquid. If the solutions are,
however, added separately, most of the product will be formed
at the centre of the channel where LuCl3 and DOTA-TATE
already had time to mix by diﬀusion (Fig. 9d). This leads to
significantly slower reactions for larger diameters (see Fig. 9c).
Nevertheless, reaction times will be with less than 100 s still
smaller than those required for conventional reaction vessels
(8–15 min).22,33
Based on the simulation results obtained for the fully
mixed model, we calculated the highest flowrate possible in
micro- or milli-fluidic systems (0.1–1.5 mm ID, 1 m length) to
still achieve the residence time necessary for 99% yield, and
also determined the time required to process 3 mL of reaction
solution (Fig. 10). These 3 mL are the volume currently pro-
cessed at Erasmus MC during clinical labelling (reaction time
30 min), leading to four patient doses. Our results show that
reaction capillaries with inner diameters equal to or higher
than 500 μm will allow for processing times that are less than
12 min, which makes this reactor setup a viable option for
clinical production. However, these results do not consider
other factors such as the influence of diameter on radiolysis8
(for small diameters radiolysis can be reduced, if the range of
radiation is significant higher than the applied diameter)
or the adsorption of chemical species on the channel
walls4–6 (due to the considerable surface area adsorption can
reduce the amount of radiopharmaceutical produced). For
a microfluidic reactor that can make clinical amounts of
[177Lu]Lu-DOTA-TATE in an acceptable timeframe, these
factors will need to be taken into account.
Conclusions
In this study, we presented a microfluidic setup that can deter-
mine kinetic association rate constants of radiopharmaceuti-
cals at diﬀerent temperatures. Currently, the system is limited
to reactions that do not occur at room temperature, however,
further work is on the way to design a system suitable for all
Fig. 8 Inﬂuence of channel diameter on the reaction kinetics of
[177Lu]Lu-DOTA-TATE.
Fig. 9 Simulation results for increasing the inner diameter of the
capillary when the reactant solutions are fully mixed at the start
of the reaction (a and b), and separated with mixing occurring
through diﬀusion (c and d). Figures (a) and (c) show the formation of
Lu-DOTA-TATE for diﬀerent channel diameters. The graphs (b) and (d)
show the concentration of Lu-DOTA-TATE at the outlet of the channel
for a channel diameter of 1500 μm and a velocity of 0.05 m s−1, which
equals 20 s residence time.
Fig. 10 Dependence of highest possible ﬂowrate to achieve 99% yield
on the inner diameter of the reaction capillary, and time required for the
reaction of 3 mL reaction solution.
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types of reactions. With the current system we studied the
kinetics of the formation of [177Lu]Lu-DOTA-TATE, and deter-
mined kinetic association rate constants and Arrhenius para-
meters for the first time. The experimental work was sup-
ported by computational simulations done with COMSOL
Multiphysics®. Finally, we considered the clinical application
of our results. The synthesis of [177Lu]Lu-DOTA-TATE is
possible in a microfluidic system within 44 s at 80 °C (99%
yield). The small diameter of the reaction capillary (100 μm),
however, limits the throughput and would require high pro-
cessing times for clinical amounts. Simulations showed that
increasing the diameter to over 500 μm will allow for reaction
times of under 12 min if 3 mL reaction volume (equaling
4 patient doses) are processed. These results demonstrate that
a continuous, capillary system is a viable alternative to the
conventional, batch-wise radiolabelling technique for which
clinical reaction times of 30 min are applied.
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